KRONOX LAB SCIENCES LTD
KRONOX · General/Diversified · NSE
₹129
Current Market Price
Fair Value (DCF)
₹175
Margin of Safety
+36.1%
Updated 1d ago
YieldIQ Score
72/100
Piotroski F-Score
8/9
Economic Moat
Wide
Confidence
60%
ROE
—
Debt/Equity
0.03
WACC
11.1%
Market Cap
₹478 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
38.0%
Return on capital employed
EV / EBITDA
13.1×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
7.28×
Short-term liquidity
Asset Turnover
1.01×
Revenue per ₹ of assets
Revenue CAGR (3Y)
6.8%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹128.74
Bear case
₹95.12
MoS -35.3%
Base case
₹175.17
MoS +26.5%
Bull case
₹200.12
MoS +35.7%
Ratio Trends
KRONOX · last 4 annual periods
ROE
28.3%
ROCE
39.6%
Operating Margin
—
Debt / Equity
0.08×
PE
—
EV / EBITDA
—
Historical Financials
KRONOX · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹82.2 Cr | ₹95.6 Cr | ₹22.2 Cr | ₹100 Cr | +6.8% |
| EBITDA | ₹20.8 Cr | ₹23.9 Cr | ₹29.9 Cr | ₹35.7 Cr | +19.7% |
| EBIT | — | — | ₹8.4 Cr | — | +0.0% |
| PAT | ₹13.6 Cr | ₹16.6 Cr | ₹5.9 Cr | ₹25.5 Cr | +23.2% |
| EPS (diluted) | — | — | ₹1.60 | — | +0.0% |
| CFO | ₹9.0 Cr | ₹19.7 Cr | ₹17.4 Cr | ₹30.7 Cr | +50.4% |
| CapEx | ₹-3.8 Cr | ₹-8.4 Cr | — | ₹-3.1 Cr | — |
| FCF | ₹5.2 Cr | ₹11.3 Cr | — | ₹27.6 Cr | +74.2% |
| Total Assets | ₹56.8 Cr | ₹54.0 Cr | ₹74.0 Cr | ₹98.8 Cr | +20.3% |
| Total Debt | ₹3.4 Cr | ₹0.0 Cr | ₹0.0 Cr | — | — |
| Shareholders' Equity | ₹40.4 Cr | ₹44.7 Cr | ₹66.3 Cr | ₹90.1 Cr | +30.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KRONOX vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| DICIND DIC INDIA LIMITED | +27.8% | 38 | Undervalued | 4.1% | 25.6× |
| ORIENTCER ORIENT CERATECH LIMITED | -3.9% | 48 | Fairly valued | 3.5% | — |
| VINYLINDIA VINYLINDIA | — | — | Pending | 17.6% | — |
| SHALPAINTS SHALPAINTS | — | — | Pending | -25.4% | — |
| SUKHJITS SUKHJITS | — | — | Pending | 7.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for KRONOX in the last 10 years.
AI Analysis Summary
KRONOX LAB SCIENCES LTD appears undervalued by 36.1%, with a standout strength in its wide moat, and a concern being the lack of interest coverage data.
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of KRONOX →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KRONOX →
Compare
Head-to-head with peers
Compare KRONOX side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KRONOXNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.